COVID–19 NEWS   Premises listed under 'HIDE' not COVID-19 clusters - Khairy | Worried over family's safety, student remains in campus to celebrate Aidilfitri | Commonwealth leaders' meeting postponed indefinitely due to COVID-19 | MCO: Don't enter Putrajaya for social, recreational activities - Police | MCO: Don't enter Putrajaya for social, recreational activities - Police | 
BUSINESS

Smiths Medical-Ivenix partnership to revolutionise infusion management in US

05/05/2021 11:01 AM

KUALA LUMPUR, May 5 -- Smiths Medical, a global medical device leader, has formed an exclusive partnership with Ivenix Inc, positioning the companies as the first in the US to offer a comprehensive suite of infusion management solutions to meet healthcare needs across the continuum of care.

The long-term partnership, which includes a strategic investment from Smiths Medical, unites two innovators under a common goal of revolutionising infusion management to improve patient safety and meet the needs of healthcare providers today and into the future.

Ivenix, a medical technology company dedicated to eliminating infusion-related patient harm, developed the first and only large-volume infusion pump from the ground up to meet the latest US Food and Drug Administration infusion pump guidelines addressing recurring safety issues with pumps.

Smiths Medical’s complementary portfolio of market-leading infusion systems CADD®-Solis and Medfusion® include syringe and ambulatory pumps that serve adult and neonatal critical care, operating rooms, and pain management in both hospital and home. 

By adding the Ivenix Infusion System to its US product portfolio, Smiths Medical will accelerate its offering into the large-volume infusion device segment, which is estimated to be over US$2 billion, according to a statement. (US$1 = RM4.117)

“The long-term partnership between Smiths Medical and Ivenix will ensure that we are bringing the next generation of infusion management solutions to hospitals across the US and fulfills our commitment to helping connect patients to life-saving therapies and insights to providers,” said Smiths Medical Chief Executive Officer, JehanZeb Noor.

The Ivenix Infusion System includes a large-volume infusion pump with administration sets, infusion management tools and analytics to inform care and advance efficiency.

Smiths Medical will launch the Ivenix infusion System as part of its infusion portfolio in the summer of 2021.

More details at www.smiths-medical.com.

-- BERNAMA

© 2021 BERNAMA   • Disclaimer   • Privacy Policy   • Security Policy